RepublicanBill · H.R. 2821· House(119-HR-2821)

FDA Modernization Act 3.0

Rep. Carter
Age: 69 years
Georgia
Introduced
4/10/2025
Last activity
7/21/2026 — Received in the Senate.
Sponsored by
Earl Carter
Cosponsors
Republican - 20Democrat - 21
Health
  1. Introduced
  2. Passed House
  3. Awaiting Senate

What this bill would do

The FDA Modernization Act 3.0 requires the Secretary of Health and Human Services, via the Commissioner of Food and Drugs, to publish an interim final rule. This rule aims to implement previous amendments to the Federal Food, Drug, and Cosmetic Act. It directs the replacement of specific references to "animal" tests, data, and research with "nonclinical" terms within various sections of title 21 of the Code of Federal Regulations. The act also mandates adding the definition of "nonclinical test" to several specific regulatory sections. Additionally, the bill includes a technical amendment regarding the designation of subsections within the Federal Food, Drug, and Cosmetic Act.

Yes

  • Does this better protect air, water and wildlife?+5

    The shift toward nonclinical methods may reduce the reliance on animal testing.

The opposite

No question was scored the opposite.